Pressure-derived fractional flow reserve to assess serial epicardial stenoses: Theoretical basis and animal validation

Circulation

Volumn 101, Issue 15, 2000, Pages 1840-1847

  De Bruyne, Bernard ^a   Pijls, Nico H J ^b   Heyndrickx, Guy R ^b   Hodeige, Dominique ^b   Kirkeeide, Richard ^b   Gould, K Lance ^b  

^a OLV HOSPITAL   (Belgium)

^b NONE

Author keywords

Flow reserve; Stenosis

Indexed keywords

ARTICLE; CALCULATION; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY COLLATERAL CIRCULATION; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY PRESSURE; DISEASE SEVERITY; DOG; EPICARDIUM; HEMODYNAMICS; MATHEMATICAL MODEL; NONHUMAN; PRIORITY JOURNAL; STRESS; THEORY; VALIDATION PROCESS;

EID: 0034681936     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.15.1840     Document Type: Article

References (19)

1. Pijls NHJ, van Son AM, Kirkeeide RL, De Bruyne B, Gould KL. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation. 1993;87:1354-1367.
2. De Bruyne B, Baudhuin T, Melin JA, Pijls NHJ, Sys SU, Bol A, Paulus WJ, Heyndrickx GR. Coronary flow reserve calculations from pressure measurements in humans: validation with positron emission tomography. Circulation. 1994;89:1013-1022.
3. De Bruyne B, Bartunek J, Sys SU, Pijls NHJ, Heyndrickx GR, Wijns W. Simultaneous coronary pressure and flow velocity measurements in humans: feasibility, reproducibility, and hemodynamic dependence of coronary flow velocity reserve, hyperemic flow versus pressure slope index, and fractional flow reserve. Circulation. 1996;94:1842-1849.
4. Segers P, Fostier G, Neckebroeck J, Verdonck P. Assessing coronary stenosis severity: in vitro validation of the concept of fractional flow reserve. Catheter Cardiovasc Interv. 1999;46:375-379.
5. De Bruyne B, Bartunek J, Sys SU, Heyndrickx GR. Relation between myocardial fractional flow reserve calculated from coronary pressure measurements and exercise-induced myocardial ischemia. Circulation. 1995;92:39-46.
6. Pijls NHJ, Van Gelder B, Van der Voort P, Peels K, Bracke FALE, Bonnier JJRM, El Gamal MIH. Fractional flow reserve: a useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation. 1995;92:3183-3193.
7. Pijls NHJ, De Bruyne B, Peels K, Van der Voort P, Bonnier JJRM, Bartunek J, Koolen JJ. Measurement of fractional flow reserve to assess the functional severity of coronary artery stenoses. W Engl J Med. 1996; 334:1703-1708.
8. Pijls NHJ, Bech GJW, El Gamal MIH, Bonnier JJRM, De Bruyne B, Van Gelder B, Michels HR, Koolen JJ. Quantification of recruitable coronary collateral blood flow in conscious humans and its potential to predict future ischemic events. J Am Coll Cardiol. 1995;25:1522-1528.
9. Bartunek J, Marwick TH, Rodrigues AT, Vincent M, Van Schuerbeeck E, Sys SU, De Bruyne B. Dobutamine-induced wall motion abnormalities: correlations with myocardial fractional flow reserve and quantitative coronary angiography. J Am Coll Cardiol. 1996;27:1429-1436.
10. Bartunek J, Van Schuerbeek E, De Bruyne B. Comparison of exercise electrocardiography and dobutamine echocardiography with invasively assessed myocardial fractional flow reserve in evaluation of severity of coronary arterial narrowing. Am J Cardiol. 1997;79:478-481.
11. Bartunek J, Sys SU, Heyndrickx GR, Pijls NHJ, De Bruyne B. Quantitative coronary angiography in predicting functional significance of stenoses in an unselected patient cohort. J Am Coll Cardiol. 1995;26:328-334.
12. Bech GJW, De Bruyne B, Bonnier HJRM, Bartunek J, Wijns W, Peels K, Heyndrickx GR, Koolen JK, Pijls NHJ. Long-term follow-up after deferral of percutaneous transluminal coronary angioplasty of intermediate stenosis on the basis of coronary pressure measurement. J Am Coll Cardiol. 1998;31:841-847.
13. Bech GJW, Pijls NHJ, De Bruyne B, Peels KH, Michels RH, Bonnier HJRM, Koolen JJ. Usefulness of fractional flow reserve to predict clinical outcome after balloon angioplasty. Circulation. 1999;99:883-888.
14. Hanekamp CEE, Koolen JJ, Pijls NHJ, Michels RH, Bonnier HJRM. Comparison of quantitative coronary angiography, intravascular ultrasound, and coronary pressure measurement to assess optimum stent deployment. Circulation. 1999;99:1015-1021.
15. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurements. Lancet. 1986;1:307-310.
16. Vanoverschelde JL, Wijns W, Depre C, Essamri B, Heyndrickx GR, Borgers M, Bol A, Melin JA. Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study of noninfarcted collateral-dependent myocardium. Circulation. 1993;87:1513-1523.
17. De Bruyne B, Pijls NHJ, Paulus WJ, Vantrimpont PJ, Sys SU, Heyndrickx GR. Transstenotic coronary pressure gradient measurement in humans: in vitro and in vivo evaluation of a new pressure monitoring angioplasty guide wire. J Am Coll Cardiol. 1993;22:119-126.
18. De Bruyne B, Sys SU, Heyndrickx GR. Percutaneous transluminal coronary angioplasty catheters versus fluid-filled pressure monitoring guidewires for coronary pressure measurements and correlation with quantitative coronary angiography. Am J Cardiol. 1993;72: 1101-1106.
19. Gould KL. Coronary Atherosclerosis and Reversing Atherosclerosis. 2nd ed. London, UK: Arnold Publishers; 1999. Distributed by Oxford University Press.